Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rats were decapitated and the complete head stored at 4 degrees C. At various time intervals, up to a maximum of 14 days, the brains and pituitary glands were removed and fixed in formalin-picric acid. Neurosecretory material (NSM), as revealed with crotonaldehyde fuchsin, and
neurophysin
as demonstrated by means of immunoperoxidase histochemistry were localized in the hypothalamic magnocellular nuclei, median eminence and posterior pituitary gland. NSM and
neurophysin
were present in the paraventricular (PVN) and supra-optic (SON) nuceli up to periods of 14 days although the cellular morphology was disrupted after about 4 days. After 4 days there was an abundance of positive staining "droplets" in both the SON, PVN and along the nerve fibers of the supraoptico-neurohypophysial tract.
Pituitary gland
NSM and
neurophysin
were still present 14 days post mortem. The slab gradient polyacrylamide gel electrophoresis pattern of soluble proteins extracted from the posterior pituitary gland from the experimental and normal animals showed almost complete identity confirming the minimal action of proteolytic enzymes at 4 degrees C up to a period of 6 days. It is concluded that as long as the tissue is cooled, rapid fixation of hypothalamic tissue is not essential for the localization of NSM and
neurophysin
.
...
PMID:Time of fixation and the localization of Gomori-positive and neurophysin-containing structures in the rat hypothalamus. 110 5
Seventeen human fetal and neonatal pituitary glands were removed at necropsy, and analyzed for
oxytocin
content by a specific and sensitive radioimmunoassay, after homogenization in 0.4M acetic acid. Serial dilution of the pituitary extract showed parallelism with the
oxytocin
standard curve on the radioimmunoassay. Column chromatography of the pituitary gland extract gave a single peak of immunoreactive
oxytocin
as determined by the radioimmunoassay. In eight fetuses, 14 to 17 weeks' gestation, pituitary gland
oxytocin
was 10.2 +/- 5.9 ng/gland (mean +/- SE), whereas an 18-week fetus had 5.8 ng of
oxytocin
per gland.
Pituitary gland
oxytocin
content increased to 38.4 ng/gland in a 20-week fetus removed at hysterectomy, and 31.6 ng/gland in a 26-week fetus. Fetal pituitary gland
oxytocin
values were 22.1 ng/gland and 57.0 ng/gland at 32 weeks and increased significantly to 544.3 +/- 33.8 ng/gland in 1- to 5-day-old term newborn infants (n = 3). However, a 13-day-old term newborn infant had 3.7 ng of
oxytocin
per pituitary gland. The increased pituitary gland
oxytocin
content with advancing gestation was due to a significant increase in
oxytocin
concentration rather than to an increase in the weight of the pituitary gland. The findings indicate that
oxytocin
is present in fetal pituitary glands as early as 14 to 17 weeks' gestation and increases at term to 50 and 13 to 14 times more than in early midtrimester and early third-trimester pregnancy, respectively.
...
PMID:Oxytocin content of human fetal pituitary glands. 669
Pituitary gland
is a well-known endocrine tissue. The hypothalamo-neurohypophysial system, containing arginine vasopressin and
oxytocin
, shows a reversible morphological reorganization of both neurons and glial cells during chronic physiological stimulations. Since many signal transducing and cell adhesion molecules (CAMs) are recovered in membrane microdomain (MD) fractions, MDs are considered as signaling platforms of cells. In order to know the molecular background for these endocrine systems, we characterized MD-components derived from rat pituitary and found specific enrichment of several proteins in the fraction. One of them was identified as myelin protein zero (P0) with mass analysis and this result was further confirmed by a result that a specific antibody to this protein reacted to the authentic P0 protein in the myelin fraction of rat sciatic nerve. P0 is one of type-I transmembrane CAMs and a major structural component of mammalian peripheral nerve myelin. In mammals, expression of P0 has been considered to be restricted to peripheral nervous system. This result however indicates that P0 expresses more widely and its enrichment in the MD-fraction from rat pituitary suggests the participation in cell-cell communications.
...
PMID:Myelin protein zero is one of the components of the detergent-resistant membrane microdomain fraction prepared from rat pituitary. 1731 42
The hypothalamic-pituitary axis is responsible for the neuroendocrine control of several organ systems. The anterior pituitary directly affects the functions of the thyroid gland, the adrenal glands and gonads, and regulates growth, and milk production. The posterior hypophysis, through nerve connections with the hypothalamic nuclei, releases vasopressin and
oxytocin
responsible for water balance and social bonding, sexual reproduction and childbirth, respectively.
Pituitary gland
hormonal excess or deficiency results in dysregulation of metabolic pathways and mechanisms that are important for the homeostasis of the organism and are associated with increased morbidity and mortality. Cardiovascular (CV) disorders are common in pituitary disease and have a significant impact on survival. Hormonal imbalance is associated with CV complications either through direct effects on the heart structure and function and vasculature or indirectly by altering the metabolic profile. Optimal endocrine control can prevent or reverse CV defects and preserve survival and quality of life. In this review we discuss the effects of pituitary hormone excess and deficiency on the CV system. Specifically, we assess the impact of Somatotroph, Corticotroph, Gonadotroph and Lactotroph anterior pituitary axes on the CV system. The effect of posterior pituitary function on the CV system is also explored.
...
PMID:Pituitary Dysfunction as a Cause of Cardiovascular Disease. 3315 96